Two Sigma Investments, LP Codex Dna, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
N/A
-9,092 Reduced 39.62%
13,858 $25,000
Q1 2023

May 15, 2023
SELL
$1.3 - $2.15 $27,796 - $45,971
-21,382 Reduced 48.23%
22,950 $42,000
Q4 2022

Feb 14, 2023
SELL
$1.12 - $1.69 $16,319 - $24,624
-14,571 Reduced 24.74%
44,332 $53,000
Q3 2022

Nov 14, 2022
BUY
$1.7 - $2.36 $100,135 - $139,011
58,903 New
58,903 $98,000

Others Institutions Holding DNAY

# of Institutions
1
Shares Held
307
Call Options Held
0
Put Options Held
0
View Full List

About Codex DNA, Inc.

DNAY Quotes by TradingView
  • Ticker DNAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,518,200
  • Market Cap $54.6M
  • Description
  • Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...
More about DNAY
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email